| CXSL2000035 | 注射用重组肿瘤酶特异性干扰素α-2b Fc融合蛋白 | | Lyophilized | Biological Products(1) | New Drug Application | 2020-02-25 | 珠海市丽珠单抗生物技术有限公司 | Livzon Mabpharm INC | In Review | 2020-02-24 | view |
| CXSL1900130 | 重组抗人IL-17A/F人源化单克隆抗体注射液 | | Injection | Biological Products(1) | New Drug Application | 2019-11-20 | 珠海市丽珠单抗生物技术有限公司 | Livzon Mabpharm INC | In Review | 2019-11-19 | view |
| CXSL1900024 | 重组全人源抗OX40单克隆抗体注射液 | | Injection | Biological Products(1) | New Drug Application | 2019-03-19 | 珠海市丽珠单抗生物技术有限公司 | Livzon Mabpharm INC | In Review | 2019-03-18 | view |
| CXSL1700170 | 重组人源化抗人IL-6R单克隆抗体注射液 | | Injection | Biological Products(2) | New Drug Application | 2018-02-08 | 珠海市丽珠单抗生物技术有限公司 | Livzon Mabpharm INC | Certificate Issued | 2018-10-29 | view |
| CXSL1700051 | 重组全人源抗RANKL单克隆抗体注射液 | denosumab | Injection | Biological Products(1) | New Drug Application | 2017-07-25 | 珠海市丽珠单抗生物技术有限公司 | Livzon Mabpharm INC | Certificate Issued | 2017-12-21 | view |
| CXSL1700048 | 重组全人源抗RANKL单克隆抗体注射液 | denosumab | Injection | Biological Products(1) | New Drug Application | 2017-07-17 | 珠海市丽珠单抗生物技术有限公司 | Livzon Mabpharm INC | Certificate Issued | 2017-12-21 | view |
| CXSL1600125 | 注射用重组人源化抗PD-1单克隆抗体 | Recombinant humanized anti-PD-1 monoclonal antibody | Lyophilized | Biological Products(1) | New Drug Application | 2017-04-20 | 珠海市丽珠单抗生物技术有限公司 | Livzon Mabpharm INC | Certificate Issued | 2017-10-26 | view |
| CXSL1600001 | 重组抗HER2结构域Ⅱ人源化单克隆抗体注射液 | | Injection | Biological Products(1) | New Drug Application | 2016-03-30 | 珠海市丽珠单抗生物技术有限公司 | Livzon Mabpharm INC | Certificate Issued | 2016-12-08 | view |
| CXSL1500027 | 重组人鼠嵌合抗CD20单克隆抗体注射液 | rituximab | Injection | Biological Products(2) | New Drug Application | 2015-05-09 | 珠海市丽珠单抗生物技术有限公司 | Livzon Mabpharm INC | Certificate Issued | 2016-12-08 | view |
| CXSL1400155 | 注射用重组人绒促性素 | Choriogonadotropin | Lyophilized | Biological Products(15) | New Drug Application | 2015-02-26 | 珠海市丽珠单抗生物技术有限公司 | Livzon Mabpharm INC | Certificate Issued | 2016-10-11 | view |
| CXSL1200030 | 注射用重组人源化抗肿瘤坏死因子α单克隆抗体 | adalimumab | Injection | Biological Products(1) | New Drug Application | 2012-06-19 | 珠海市丽珠单抗生物技术有限公司 | Livzon Mabpharm INC | Certificate Issued | 2014-03-04 | view |
| CXSB1600010 | 注射用重组人源化抗人肿瘤坏死因子α单克隆抗体 | adalimumab | Injection | Biological Products | Supplementary Application | 2016-09-05 | 珠海市丽珠单抗生物技术有限公司 | Livzon Mabpharm INC | Certificate Issued | 2016-11-17 | view |
| CXSB1600009 | 注射用重组人源化抗人肿瘤坏死因子α单克隆抗体 | adalimumab | Injection | Biological Products | Supplementary Application | 2016-09-05 | 珠海市丽珠单抗生物技术有限公司 | Livzon Mabpharm INC | Certificate Issued | 2016-11-17 | view |
